Financial Performance

Melcor Developments is betting on itself with a massive share buyback. Is it a savvy move to exploit an undervalued stock or a bold signal of confidence?

As travel habits shift, new business models and government incentives are making Canada's waterways more accessible than ever, fueling a multi-billion dollar industry.

A tech firm with a history of pivots, Mitesco is launching an AI real estate tool. Can its unique strategy of deep industry collaboration overcome financial headwinds?

Altera's Agilex 9 FPGA packs RF, compute, and memory into one chip, promising a leap in performance for defense, aerospace, and next-gen communications.

Eikon Therapeutics adds a consumer goods giant to its board, a move signaling a strategic pivot from pure science to global commercialization.

Truist's appointment of Lindsey Stampone isn't just a new hire; it's a calculated move to challenge rivals in the competitive PA & NJ banking markets.

After years of stabilization, a 90% stake in real estate firm DEMIRE is for sale. The move by Apollo and Wecken & Cie. could reshape the firm and signal a market shift.

Metropolitan Dermatology is the first in NJ to adopt Nevisense®, an AI-backed scanner for melanoma. Is this tech a true game-changer or one move in a complex market?

Promising early data for obesity drug DA-1726 shows rapid weight loss, while vanoglipel demonstrates powerful synergy in MASH and diabetes combination therapies.

BestFarewell's appointment of Rianka Dorsainvil isn't just a hire; it's a signal. A look at how AI and human expertise are converging in a new system for legacy.

Hub International appoints Faizal Mitha as VP of AI Sales Innovation, a move to embed AI in sales and drive growth, setting a new bar for the industry.

A key hospitality tech acquisition signals a major shift from fixing Wi-Fi problems to proactively validating the entire network, a move with broad implications.

Global outdoor brand BLACKYAK moves beyond declarations, taking its climate summit to the Himalayan frontlines to launch a concrete action plan with local communities.

New trial data shows Sequel Med Tech's twiist™ AID system could bring much-needed simplicity and safety to millions with insulin-treated type 2 diabetes.

CAMIN’s appointment of Tom Parks as CFO is more than a personnel change. It's a clear signal of a strategic bet on technology to redefine a critical global industry.

Ares Capital, a giant in middle-market finance, just opened a new $1B funding spigot. Is this a blueprint for the BDC industry or a sign of cheaper capital for American businesses?

How new high-resolution analysis at Canadian GoldCamps' flagship project is de-risking a complex deposit and revealing its true high-grade potential.

As Einride finalizes its public debut, a new partnership with Scan Sverige to electrify refrigerated freight signals a major breakthrough for the industry.

A Chinese medical device company just won top honors from global investors. It's not just a trophy—it's a masterclass in corporate strategy and global ambition.

As FACE Coalition’s Melamoon tour lands in Halifax, it's clear this is more than a pitch contest. It’s a strategic move to dismantle systemic barriers.